G Cannata
Impact in
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
- Cancer and Skin Lesions
- Otorhinolaryngology top 5%
Papers in
- Co-authors
- Vittorio Gebbia (19 shared papers)Roberto Valenza (12 shared papers)S. Barbaro (4 shared papers)S. Coppolino (4 shared papers)Fernando De Maio (1 shared paper)Ernesto Ippolito (1 shared paper)Federico Mancini (1 shared paper)Emmanuel Sinagra (3 shared papers)
- Journals
- American Journal of Dermatopathology (5 papers)Solar Energy (4 papers)Oncology Reports (3 papers)Anti-Cancer Drugs (3 papers)Cancer (2 papers)
- Partner nations
- ItalyFranceUnited Kingdom
In The Last Decade
G Cannata
43 papers receiving 732 citations
Peers
Comparison fields: 5 of 92
- Dermatology 175
- Otorhinolaryngology 55
- Rehabilitation 68
- Epidemiology 269
- Surgery 270
Countries citing papers authored by G Cannata
This map shows the geographic impact of G Cannata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Cannata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Cannata more than expected).
Fields of papers citing papers by G Cannata
This network shows the impact of papers produced by G Cannata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Cannata. The network helps show where G Cannata may publish in the future.
Co-authors
The 25 scholars most cited alongside G Cannata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 92 | |
| 2 | 1981 | 77 | |
| 3 | 2010 | 62 | |
| 4 | 1994 | 56 | |
| 5 | 1993 | 53 | |
| 6 | 1993 | 34 | |
| 7 | 2011 | 34 | |
| 8 | 2011 | 31 | |
| 9 | Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma. | 1994 | 28 |
| 10 | Incidence of fragility fractures. | 2007 | 27 |
| 11 | 1981 | 26 | |
| 12 | 1995 | 22 | |
| 13 | 1993 | 21 | |
| 14 | A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy. | 1994 | 19 |
| 15 | Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients. | 1994 | 16 |
| 16 | 2008 | 16 | |
| 17 | 1996 | 15 | |
| 18 | Surgical approach to fragility fractures: problems and perspectives. | 2007 | 15 |
| 19 | 2016 | 14 | |
| 20 | 1995 | 14 |
About G Cannata
G Cannata is a scholar working on Oncology, Surgery, Dermatology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 764 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Nail Diseases and Treatments (6 papers), Cancer and Skin Lesions (6 papers), Neutropenia and Cancer Infections (5 papers), Solar Thermal and Photovoltaic Systems (4 papers), Solar Radiation and Photovoltaics (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Head and Neck Cancer Studies (4 papers). The work is most often cited by research in Dermatology (175 citations), Otorhinolaryngology (55 citations), Rehabilitation (68 citations), Epidemiology (269 citations) and Surgery (270 citations). G Cannata has collaborated with scholars based in Italy, France and United Kingdom. Frequent co-authors include Vittorio Gebbia, Roberto Valenza, S. Barbaro, S. Coppolino, Fernando De Maio, Ernesto Ippolito, Federico Mancini, Emmanuel Sinagra, Christophe Perrin and Cláudio Leone. Their work appears in journals such as American Journal of Dermatopathology, Solar Energy, Oncology Reports, Anti-Cancer Drugs and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.